Profile data is unavailable for this security.
About the company
Milestone Pharmaceuticals Inc. is a Canada-based biopharmaceutical company. The Company is focused on the development and commercialization of cardiovascular medicines. Its lead product candidate, etripamil, is a potent rapid-onset calcium channel blocker that the Company designed and is developing as a rapid-onset nasal spray to be administered by patients. The Company is also focused on developing etripamil to treat paroxysmal supraventricular tachycardia (PSVT) with a subsequent indication to treat atrial fibrillation with rapid ventricular rate (AFib-RVR) and other cardiovascular indications.
- Revenue in USD (TTM)0.00
- Net income in USD-55.09m
- Incorporated2003
- Employees47.00
- LocationMilestone Pharmaceuticals Inc420-1111 boul. Dr.-Frederik-PhilipsMONTREAL H4M 2X6CanadaCAN
- Phone+1 (514) 336-0444
- Fax+1 (514) 336-0444
- Websitehttps://www.milestonepharma.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Serina Therapeutics Inc | 137.00k | -20.96m | 67.31m | 4.00 | -- | -- | -- | 491.32 | -14.07 | -14.07 | 0.0909 | -0.5121 | 0.0117 | -- | 3.86 | 34,250.00 | -179.27 | -194.46 | -- | -- | 67.88 | 85.80 | -15,301.46 | -2,347.36 | -- | -0.9274 | 1.70 | -- | 317.65 | -36.69 | -41.49 | -- | -- | -- |
enVVeno Medical Corp | 0.00 | -22.12m | 67.58m | 31.00 | -- | 1.60 | -- | -- | -1.70 | -1.70 | 0.00 | 3.18 | 0.00 | -- | -- | 0.00 | -54.31 | -58.43 | -56.14 | -62.76 | -- | -- | -- | -260,799.30 | -- | -- | 0.00 | -- | -- | -- | 4.67 | -- | 21.58 | -- |
Celularity Inc | 14.79m | -181.41m | 67.64m | 225.00 | -- | 1.99 | -- | 4.57 | -10.51 | -10.51 | 0.8376 | 1.56 | 0.0498 | 2.29 | 2.03 | 65,724.45 | -61.05 | -- | -82.37 | -- | 21.19 | -- | -1,226.72 | -- | 0.1366 | 18.40 | 0.5365 | -- | -15.75 | -- | 114.18 | -- | -- | -- |
Medicinova Inc | 1.00m | -8.41m | 68.66m | 13.00 | -- | 1.15 | -- | 68.66 | -0.1714 | -0.1714 | 0.0204 | 1.22 | 0.0149 | -- | -- | 76,923.08 | -12.55 | -15.36 | -13.06 | -15.90 | -- | -- | -840.85 | -1,182.54 | -- | -- | 0.00 | -- | -- | -- | 39.08 | -- | 15.87 | -- |
Kronos Bio Inc | 7.59m | -116.39m | 70.31m | 61.00 | -- | 0.5133 | -- | 9.27 | -2.00 | -2.00 | 0.1301 | 2.28 | 0.0322 | -- | -- | 122,371.00 | -49.32 | -35.47 | -54.43 | -37.14 | -- | -- | -1,534.11 | -7,975.76 | -- | -- | 0.00 | -- | -- | -- | 15.41 | -- | -8.78 | -- |
Spero Therapeutics Inc | 110.98m | 23.40m | 70.45m | 46.00 | 3.10 | 0.7304 | 2.97 | 0.6348 | 0.4213 | 0.4213 | 2.08 | 1.79 | 0.792 | -- | 3.96 | 2,412,565.00 | 16.70 | -35.52 | 21.73 | -41.75 | -- | -- | 21.09 | -124.40 | -- | -- | 0.00 | -- | 93.95 | 92.11 | 149.14 | -- | -- | -- |
Prenetics Global Ltd | 22.25m | -49.97m | 70.98m | 320.00 | -- | 0.3099 | -- | 3.19 | -4.33 | -5.32 | 1.91 | 18.75 | 0.0832 | 3.89 | 4.53 | 69,535.41 | -19.43 | -- | -23.55 | -- | 45.56 | -- | -233.41 | -- | 2.25 | -5.17 | 0.0086 | -- | 65.17 | -- | 75.91 | -- | -- | -- |
Milestone Pharmaceuticals Inc | 0.00 | -55.09m | 71.90m | 47.00 | -- | 1.80 | -- | -- | -1.25 | -1.25 | 0.00 | 0.7498 | 0.00 | -- | -- | 0.00 | -53.21 | -48.44 | -56.51 | -51.56 | -- | -- | -- | -1,267.25 | -- | -- | 0.5592 | -- | -80.00 | -- | -2.22 | -- | 86.23 | -- |
Anixa Biosciences Inc | 0.00 | -11.60m | 72.65m | 4.00 | -- | 3.08 | -- | -- | -0.3694 | -0.3694 | 0.00 | 0.7381 | 0.00 | -- | -- | 0.00 | -45.19 | -59.69 | -46.33 | -62.61 | -- | -- | -- | -6,040.10 | -- | -- | 0.00 | -- | -- | -28.36 | 27.83 | -- | -- | -- |
Cognition Therapeutics Inc | 0.00 | -28.77m | 72.91m | 25.00 | -- | 2.52 | -- | -- | -0.9155 | -0.9155 | 0.00 | 0.7218 | 0.00 | -- | -- | 0.00 | -68.08 | -- | -85.18 | -- | -- | -- | -- | -- | -- | -251.59 | 0.00 | -- | -- | -- | -20.52 | -- | -- | -- |
Maia Biotechnology Inc | 0.00 | -23.72m | 73.15m | 13.00 | -- | -- | -- | -- | -1.57 | -1.57 | 0.00 | -0.2801 | 0.00 | -- | -- | 0.00 | -266.70 | -- | -520.49 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -21.91 | -- | -- | -- |
FibroGen Inc | 167.49m | -240.46m | 73.91m | 486.00 | -- | -- | -- | 0.4413 | -2.45 | -2.45 | 1.70 | -2.29 | 0.3704 | 1.18 | 5.05 | 344,635.80 | -53.71 | -30.62 | -124.24 | -42.31 | 75.46 | 93.52 | -145.02 | -119.08 | 1.27 | -36.51 | -- | -- | 4.99 | -7.05 | 3.21 | -- | -20.67 | -- |
Verastem Inc | 0.00 | -105.52m | 74.33m | 73.00 | -- | 2.96 | -- | -- | -4.40 | -4.40 | 0.00 | 1.83 | 0.00 | -- | -- | 0.00 | -86.34 | -62.70 | -108.04 | -75.18 | -- | -- | -- | -406.17 | -- | -- | 0.4703 | -- | -100.00 | -- | -18.36 | -- | -- | -- |
Allakos Inc | 0.00 | -214.44m | 74.43m | 131.00 | -- | 0.7094 | -- | -- | -2.45 | -2.45 | 0.00 | 1.18 | 0.00 | -- | -- | 0.00 | -81.27 | -42.71 | -92.78 | -45.11 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 41.96 | -- | -38.89 | -- |
Connect Biopharma Holdings Ltd (ADR) | 0.00 | -59.50m | 76.04m | 81.00 | -- | 0.7854 | -- | -- | -1.08 | -1.08 | 0.00 | 1.76 | -- | -- | -- | 0.00 | -- | -66.24 | -- | -71.36 | -- | -- | -- | -- | -- | -- | 0.0046 | -- | -- | -- | 49.61 | -- | 10.32 | -- |
Data as of Jul 03 2024. Currency figures normalised to Milestone Pharmaceuticals Inc's reporting currency: US Dollar USD
44.38%Per cent of shares held by top holders
Holder | Shares | % Held |
---|---|---|
BlackRock Financial Management, Inc.as of 31 Mar 2024 | 4.71m | 8.84% |
RTW Investments LPas of 31 Mar 2024 | 3.26m | 6.11% |
Millennium Management LLCas of 31 Mar 2024 | 2.86m | 5.36% |
Alta Fundamental Advisers LLCas of 31 Mar 2024 | 2.37m | 4.45% |
Lion Point Capital LPas of 31 Mar 2024 | 2.30m | 4.32% |
Citadel Advisors LLCas of 31 Mar 2024 | 2.25m | 4.23% |
Nantahala Capital Management LLCas of 31 Mar 2024 | 1.75m | 3.29% |
Stonepine Capital Management LLCas of 31 Mar 2024 | 1.46m | 2.75% |
Goldman Sachs & Co. LLC (Private Banking)as of 31 Mar 2024 | 1.35m | 2.54% |
Bleichroeder LPas of 31 Mar 2024 | 1.33m | 2.49% |
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.